Showing results (311-320 of 1,284) with videos related to
Sort By:
Pageof 129
Diabetes, Obesity & Metabolism|November 28, 2017
Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 yearsShani Botha, Lorna Forde, Sheila MacNaughton, et al.Endocrine Reviews|July 26, 2012
Cardiometabolic aspects of the polycystic ovary syndromeHarpal S Randeva, Bee K Tan, Martin O Weickert, et al.Lancet (London, England)|August 22, 2018
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort studyAraz Rawshani, Naveed Sattar, Stefan Franzén, et al.Current Opinion in Anaesthesiology|April 12, 2016
The challenges of implementing electronic health records for anesthesia use outside the operating roomEthan Y Brovman, David Preiss, Richard D Urman, et al.Circulation|August 9, 2006
Adiponectin and coronary heart disease: a prospective study and meta-analysisNaveed Sattar, Goya Wannamethee, Nadeem Sarwar, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 26, 2005
The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphomaMaqsood M Elahi, Donald C McMillan, Colin S McArdle, et al.Stroke|October 11, 2008
Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trialScott W Muir, Craig Harrow, Jesse Dawson, et al.Diabetologia|June 1, 2021
Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational studyMoa Lugner, Soffia Gudbjörnsdottir, Naveed Sattar, et al.Diabetes, Obesity & Metabolism|February 15, 2022
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomesSabine Kahl, Anne Pernille Ofstad, Bernard Zinman, et al.JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.Pageof 129